Literature DB >> 13104803

Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria.

W C COOPER, A V MYATT, T HERNANDEZ, G M JEFFERY, G R COATNEY.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/effects; MALARIA/experimental

Mesh：

Substances：

Year:  1953        PMID： 13104803

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  16 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

2.  Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys.

Authors:  L H Schmidt
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

3.  Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report.

Authors:  A S ALVING; C F JOHNSON; A R TARLOV; G J BREWER; R W KELLERMEYER; P E CARSON
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

4.  Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.

Authors:  Inge Sutanto; Bagus Tjahjono; Hasan Basri; W Robert Taylor; Fauziah A Putri; Rizka A Meilia; Rianto Setiabudy; Siti Nurleila; Lenny L Ekawati; Iqbal Elyazar; Jeremy Farrar; Herawati Sudoyo; J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

5.  Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers.

Authors:  L H Schmidt; S Alexander; L Allen; J Rasco
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

6.  Use of quinocide in treatment and prophylaxis of vivax malaria.

Authors:  A Y LYSENKO
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

7.  Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria.

Authors:  Sasithon Pukrittayakamee; Kesinee Chotivanich; Arun Chantra; Ralf Clemens; Sornchai Looareesuwan; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

8.  Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.

Authors:  Brioni R Moore; Sam Salman; John Benjamin; Madhu Page-Sharp; Leanne J Robinson; Elizabeth Waita; Kevin T Batty; Peter Siba; Ivo Mueller; Timothy M E Davis; Inoni Betuela
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

Review 9.  Determinants of relapse periodicity in Plasmodium vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2011-10-11       Impact factor: 2.979

10.  Imported tertian malaria resistant to primaquine.

Authors:  D J Na; J D Han; D Y Cha; I K Song; H W Choi; E A Chung; C W Park; J S Choi
Journal:  Korean J Intern Med       Date:  1999-07       Impact factor: 2.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.